Effect of a single pill concept on clinical and pharmacoeconomic outcomes in cardiovascular diseases.

SPC is associated with lower incidence rates of CV events, time to CV events, and all-cause death, and is superior regarding pharmacoeconomic parameters and should therefore become standard of care to improve outcomes and reduce healthcare costs.